Home » Bristol-Myers Enters Into Immuno-Oncology Collaboration with Ono Pharmaceutical
Bristol-Myers Enters Into Immuno-Oncology Collaboration with Ono Pharmaceutical
Bristol-Myers Squibb and Ono Pharmaceutical have entered into a strategic agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens for cancer patients in Japan, South Korea and Taiwan.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May